Dr. Fruehauf is a physician-scientist and life-science entrepreneur. He is the President and CEO of Biolabs, the national network for biotech co-working spaces and the Executive Director of LabCentral, the largest co-working space for life-science companies in the Boston area. Together, these organisations span all of the major biotech markets in the US and comprise a large number of start-up companies (over 150 currently, over 200 companies graduated). The concept of these facilities is built around openness, transparency and shared resources and has changed the way biotech companies are built in the US. Companies launched at Biolabs/LabCentral have raised over $2bn in venture capital financing since 2010.
Dr. Fruehauf is a General Partner at BioInnovation Capital, an early stage venture capital fund providing capital to start-up companies in the life sciences.
Dr. Fruehauf studied Medicine in Germany and France. He practiced medicine (internal medicine and OB/Gyn) for several years in Germany before coming to Boston for a post-doc at Beth Israel Deaconess Medical Center/Harvard Medical School. He is an author of 30 peer reviewed articles in the medical literature and inventor on numerous issued and pending patents, mostly on drug delivery and RNAi technologies.